Heparin-induced thrombocytopenia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Heparin-induced thrombocytopenia differential diagnosis": Robot: Protecting all pages from category Drugs ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
No edit summary
 
(15 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Heparin-induced thrombocytopenia}}
__NOTOC__
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Heparin-induced_thrombocytopenia]]
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com] {{shyam}}
 
==Overview==
==Overview==
[[Heparin-induced thrombocytopenia]] is diagnosed when the [[platelet]] count falls by > 50% typically after 5-10 days of [[heparin]] therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, Thrombotic thrombocytopenia and others.
[[Heparin-induced thrombocytopenia]] is diagnosed when the [[platelet]] count falls by > 50% typically after 5-10 days of [[heparin]] therapy. It should be differentiated by other causes of thrombocytopenia like [[Hemolytic-uremic syndrome|hemolytic uremic syndrome]], t[[Thrombotic thrombocytopenia|hrombotic thrombocytopenia]], [[disseminated intravascular coagulation]], [[post-transfusion purpura]], and [[systemic lupus erythematosis]].


==Differential diagnosis==
==Differential diagnosis==
Diagnosis of [[Heparin-induced thrombocytopenia]] is mainly done with the help of lab tests. A decrease in [[platelet]] count by > 50% typically after 5-10 days of [[heparin]] therapy leads to a diagnosis of [[HIT]]. Thus, it should be differentiated from other causes of thrombocytopenia like


* [[Disseminated Intravascular Coagulation]]
HIT must be differentiated from other diseases that present with thrombocytopenia. Please scroll down to view the table.
* [[Thrombotic Thrombocytopenic Purpura]]
{| class="wikitable"
* [[Hemolytic-Uremic Syndrome]]
! scope="col" | Characteristic/Parameter
* [[Immune Thrombocytopenic Purpura]]
! scope="col" | '''HIT'''
* [[Drug-Induced Thrombocytopenia]]  
! scope="col" | '''DIC'''
* [[Posttransfusion Thrombocytopenia]]
! scope="col" | '''HUS'''<ref name="pmid28416508">{{cite journal| author=Jokiranta TS| title=HUS and atypical HUS. | journal=Blood | year= 2017 | volume= 129 | issue= 21 | pages= 2847-2856 | pmid=28416508 | doi=10.1182/blood-2016-11-709865 | pmc=5445567 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28416508  }} </ref>
* [[Systemic Lupus Erythematosus]]
! scope="col" | '''Atypical HUS'''
! scope="col" | '''ITP'''
! scope="col" | '''PTP'''
! scope="col" | '''SLE'''
|-
! scope="row" | Symptoms
| [[Bleeding]], [[thrombosis]], [[Necrosis|skin necrosis]]
| [[Bleeding]], [[thrombosis]], [[petechiae]], [[sepsis]]
| [[Renal failure]], [[hematuria]], [[bleeding]], [[microangiopathic hemolytic anemia]]
| [[Renal failure]], [[hematuria]], [[bleeding]], [[microangiopathic hemolytic anemia]]
| [[Petechiae]], [[bleeding]], other [[autoimmune diseases]]
| [[Petechia]]<nowiki/>e, [[purpura]], [[ecchymoses]]
| [[Bleeding]], [[photosensitivity]], [[arthritis]], [[malar rash]], discoid rash, [[Renal insufficiency|renal failure]], [[seizures]], [[psychosis]]
|-
! scope="row" | Platelet count
| Low but usually more than 20000 per microliter
| Low
| Low
| Low
| Low; can be as low as 10000 per microliter
| Low; can be less than 10000 per microliter; sudden onset after [[transfusion]]
| Variable; usually low
|-
! scope="row" | PT and PTT
| Normal
| Elevated
| Normal
| Normal
| Normal
| Normal
| Usually normal
|-
! scope="row" | Etiology
| [[Heparin]] exposure
| [[Sepsis]], delivery of fetus, [[acute promyelocytic leukemia]], other [[malignancy]]
| [[Escherichia coli O157:H7|E.coli strain O157:H7]]; [[Shiga-like toxin]]
| Dysregulation of [[Complement|complement activation]]; mutation in [[Factor H|complement factor H]]
| Idiopathic; can be secondary to [[chronic lymphocytic leukemia]], [[Human Immunodeficiency Virus (HIV)|HIV]], [[Hepatitis|viral hepatitis]], [[H. pylori]]
| Exposure to transfused products
| Autoimmunity with development of [[antibodies]] to [[DNA]]
|-
! scope="row" | Drug-related
| Yes, always
| Possible
| No
| No
| Yes
| No; transfusion-related
| Possible; drug-induced lupus can be caused by medications like [[hydralazine]] or [[isoniazid]]
|-
! scope="row" | Bleeding
| Possible
| Usually
| Usually
| Usually
| Yes; spontaneous bleeding if [[platelet]] count < 10000 per microliter
| Yes; spontaneous bleeding if platelet count < 10000 per microliter
| Rare
|}
 
Table legend: '''HIT''', heparin-induced thrombocytopenia; '''DIC''', disseminated intravascular coagulation; '''HUS''', hemolytic-uremic syndrome; '''ITP''', immune thrombocytopenia purpura; '''PTP''', post-transfusion purpura; '''SLE''', systemic lupus erythematosis


==Reference==
==Reference==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Drugs]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Up-To-Date]]
 
{{WS}}
{{WH}}

Latest revision as of 21:08, 26 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2] Shyam Patel [3]

Overview

Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, thrombotic thrombocytopenia, disseminated intravascular coagulation, post-transfusion purpura, and systemic lupus erythematosis.

Differential diagnosis

HIT must be differentiated from other diseases that present with thrombocytopenia. Please scroll down to view the table.

Characteristic/Parameter HIT DIC HUS[1] Atypical HUS ITP PTP SLE
Symptoms Bleeding, thrombosis, skin necrosis Bleeding, thrombosis, petechiae, sepsis Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia Petechiae, bleeding, other autoimmune diseases Petechiae, purpura, ecchymoses Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Platelet count Low but usually more than 20000 per microliter Low Low Low Low; can be as low as 10000 per microliter Low; can be less than 10000 per microliter; sudden onset after transfusion Variable; usually low
PT and PTT Normal Elevated Normal Normal Normal Normal Usually normal
Etiology Heparin exposure Sepsis, delivery of fetus, acute promyelocytic leukemia, other malignancy E.coli strain O157:H7; Shiga-like toxin Dysregulation of complement activation; mutation in complement factor H Idiopathic; can be secondary to chronic lymphocytic leukemia, HIV, viral hepatitis, H. pylori Exposure to transfused products Autoimmunity with development of antibodies to DNA
Drug-related Yes, always Possible No No Yes No; transfusion-related Possible; drug-induced lupus can be caused by medications like hydralazine or isoniazid
Bleeding Possible Usually Usually Usually Yes; spontaneous bleeding if platelet count < 10000 per microliter Yes; spontaneous bleeding if platelet count < 10000 per microliter Rare

Table legend: HIT, heparin-induced thrombocytopenia; DIC, disseminated intravascular coagulation; HUS, hemolytic-uremic syndrome; ITP, immune thrombocytopenia purpura; PTP, post-transfusion purpura; SLE, systemic lupus erythematosis

Reference

  1. ↑ Jokiranta TS (2017). "HUS and atypical HUS". Blood. 129 (21): 2847–2856. doi:10.1182/blood-2016-11-709865. PMC 5445567. PMID 28416508.

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Heparin-induced_thrombocytopenia_differential_diagnosis&oldid=1554524"